CRCdx® RAS Mutation Detection

FDA-approved real-time PCR-based companion diagnostic for the detection of KRAS and NRAS mutations in colorectal cancer to support informed treatment decisions

Benchbot® 4800

​Streamline Your Workflow: From Sample to PCR Plate in Four Simple Steps

NPM1 One-Step MRD Kit

Highly sensitive assay detects NPM1 mutations at a 0.001% sensitivity level, providing quantitative MRD assessment.

Automation

Reagents

Software

Uncompromising
Quality & Support

All EntroGen products are manufactured in accordance with ISO 13485 standards.

Learn More

EntroGen to Highlight MGMT Methylation Testing at AMP 2026

EntroGen, Inc. will participate in the Association for Molecular Pathology (AMP) 2026 Annual Meeting in Seattle, Washington, where the company will highlight its MGMT Methylation Detection Kit and share laboratory experiences evaluating real-time PCR as an approach to...
Read More

Roadmap for Clinical Trial Assays and Companion Diagnostic Development at World CDx 2026

EntroGen participated in the 16th World Clinical Biomarkers & Companion Diagnostics Summit, held October 5–8 in Boston, bringing together leaders in pharmaceutical development, diagnostics, and precision medicine. Matthew Maland, Director of Regulatory Affairs at...
Read More

EntroGen Launches DPYD Genotyping Kit

EntroGen, Inc., a leading provider of molecular diagnostic solutions in oncology, announced the launch of its DPYD Genotyping Kit (RUO) — a multiplex real-time PCR assay designed to enable rapid and reliable detection of clinically relevant DPYD germline variants...
Read More

EntroGen Newsletter

Receive quarterly updates on EntroGen news and products.

Subscribe now

Get in touch with us